Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 14/20 | 0.63 |
| ▸ | DCTPP1 | Q9H773 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1600483 | 0.89 | SCD (0.61) | SCD | |
| SCHEMBL1600928 | 0.88 | SCD (0.63) | SCD | |
| SCHEMBL1601034 | 0.84 | SCD (0.65) | SCDDCTPP1CYP2C9CYP2C19HTR2B | |
| SCHEMBL1601644 | 0.83 | SCD (0.63) | SCDDCTPP1 | |
| SCHEMBL1601596 | 0.82 | SCD (0.67) | SCDDCTPP1CYP2C9CYP2C19HTR2B | |
| SCHEMBL1599697 | 0.81 | SCD (0.75) | SCDDCTPP1CYP2C9CYP2C19HTR2B | |
| SCHEMBL1599942 | 0.80 | SCD (0.65) | SCDDCTPP1CYP2C9CYP2C19HTR2B | |
| SCHEMBL1601035 | 0.79 | SCD (0.90) | SCDDCTPP1 | |
| SCHEMBL1600545 | 0.79 | SCD (0.57) | SCDDCTPP1 | |
| SCHEMBL2468596 | 0.78 | SCD (0.68) | SCDDCTPP1CYP2C9CYP2C19HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1651605-B1 | PYRIDYL DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC (CA) | 2012-05-02 | — | — | EP | claimed |
| EP-1846035-B1 | COMBINATION THERAPY | XENON PHARMACEUTICALS INC (CA) | 2011-09-21 | — | — | EP | claimed |
| EP-1846035-B1 | COMBINATION THERAPY | XENON PHARMACEUTICALS INC (CA) | 2011-09-21 | — | — | EP | disclosed |
| US-7919484-B2 | Combination therapy | XENON PHARMACEUTICALS INC. (CA) | 2011-04-05 | — | — | US | disclosed |